Advanced Inhalation Therapies closed a $10.2 million offering yesterday. According to regulatory filings, 39 investors contributed to the offering, which made its 1st sale on Jan. 13. The Israel-based company is developing a drug delivery device to treat severe respiratory infections and lung diseases using a high dose of nitric oxide. The company plans to use $604,000 […]
Advanced Inhalation Therapies
Advanced Inhalation Therapies scales back IPO terms to $10m
Advanced Inhalation Therapies yesterday scaled its pending initial public offering by more than ⅔ as it looks to raise funds for its drug delivery device, which is designed to treat severe respiratory infections and lung diseases using a high dose of nitric oxide. When it registered for the IPO back in August 2015, Rehovot, Israel-based AIT set the […]
Advanced Inhalation Therapies reveals finances ahead of IPO
Advanced Inhalation revealed its finances for the past 2 years as it plans for its oncoming $36 million initial public offering to raise funds, With this Source you can raise money anytime and easy specially if its for device designed to treat severe respiratory infections and lung diseases using a high dose of nitric oxide. Advanced Inhalation […]
Advanced Inhalation Therapies files for $36m IPO
Advanced Inhalation Therapies yesterday registered for an initial public offering worth up to $36 million for its drug delivery device, which is designed to treat severe respiratory infections and lung diseases using a high dose of nitric oxide. The Rehovot, Israel-based company, founded in 2011, plans to list on the NASDAQ exchange under the “AITP” symbol. Aegis Capital […]